IS2709B - Aðferð til framleiðslu á amín platínu komplexum - Google Patents

Aðferð til framleiðslu á amín platínu komplexum

Info

Publication number
IS2709B
IS2709B IS6092A IS6092A IS2709B IS 2709 B IS2709 B IS 2709B IS 6092 A IS6092 A IS 6092A IS 6092 A IS6092 A IS 6092A IS 2709 B IS2709 B IS 2709B
Authority
IS
Iceland
Prior art keywords
amine
preparation
platinum complexes
complexes
platinum
Prior art date
Application number
IS6092A
Other languages
English (en)
Other versions
IS2711B3 (is
IS6092A (is
Inventor
Ernest S Y Wong
Christen M Giandomenico
Original Assignee
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc filed Critical Anormed Inc
Publication of IS6092A publication Critical patent/IS6092A/is
Publication of IS2709B publication Critical patent/IS2709B/is
Publication of IS2711B3 publication Critical patent/IS2711B3/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
IS6092A 1999-04-13 2001-09-28 Aðferð til framleiðslu á amín platínu komplexum IS2711B3 (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12893999P 1999-04-13 1999-04-13
PCT/CA2000/000385 WO2000061590A1 (en) 1999-04-13 2000-04-11 Process for preparing amine platinum complexes

Publications (3)

Publication Number Publication Date
IS6092A IS6092A (is) 2001-09-28
IS2709B true IS2709B (is) 2011-01-15
IS2711B3 IS2711B3 (is) 2011-01-15

Family

ID=22437722

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6092A IS2711B3 (is) 1999-04-13 2001-09-28 Aðferð til framleiðslu á amín platínu komplexum

Country Status (32)

Country Link
US (1) US6518428B1 (is)
EP (1) EP1165576B1 (is)
JP (1) JP4756669B2 (is)
KR (1) KR100711955B1 (is)
CN (3) CN100460412C (is)
AR (1) AR043084A1 (is)
AT (1) ATE309257T1 (is)
AU (1) AU770006B2 (is)
BG (1) BG65429B1 (is)
BR (1) BR0009780B1 (is)
CA (1) CA2368849C (is)
CY (1) CY1104965T1 (is)
CZ (1) CZ303156B6 (is)
DE (1) DE60023859T2 (is)
DK (1) DK1165576T3 (is)
EE (1) EE04747B1 (is)
ES (1) ES2253214T3 (is)
HK (2) HK1039336B (is)
HU (1) HUP0200748A3 (is)
IL (1) IL145671A0 (is)
IS (1) IS2711B3 (is)
MX (1) MXPA01010430A (is)
MY (1) MY122706A (is)
NO (1) NO330429B1 (is)
NZ (1) NZ514736A (is)
PL (1) PL202731B1 (is)
RU (1) RU2245340C2 (is)
SK (1) SK286374B6 (is)
TW (1) TWI289565B (is)
UA (1) UA71614C2 (is)
WO (1) WO2000061590A1 (is)
ZA (1) ZA200107965B (is)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
US6413953B1 (en) * 1999-04-13 2002-07-02 Anormed Inc. Pt(IV) antitumor agent
WO2000061590A1 (en) 1999-04-13 2000-10-19 Anormed, Inc. Process for preparing amine platinum complexes
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
US6806289B1 (en) * 2000-07-14 2004-10-19 Stephen J. Lippard Coordination complexes, and methods for preparing by combinatorial methods, assaying and using the same
US6894049B1 (en) 2000-10-04 2005-05-17 Anormed, Inc. Platinum complexes as antitumor agents
ES2308451T3 (es) 2004-02-18 2008-12-01 Gpc Biotech Ag Satraplatino para el tratamiento de tumores resistentes o refractarios.
CZ2004964A3 (cs) * 2004-09-14 2006-03-15 Pliva-Lachema A. S. Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
ES2257178B1 (es) * 2004-09-30 2007-08-16 Universidad Autonoma De Madrid Compuestos de platino de formula trans-(ptc12(isopropilamina)(4-(hidroximetil)-piridina)) y trans-(ptc12(isopropilamina)(3-hidroximetil)-piridina y su aplicacion como farmaco antitumoral.
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168661B2 (en) * 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US20110033528A1 (en) * 2009-08-05 2011-02-10 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
EP2178893A4 (en) * 2007-07-16 2012-09-19 Poniard Pharmaceuticals Inc ORAL FORMULATIONS FOR PICOPLATIN
CN102014624A (zh) * 2008-02-08 2011-04-13 帕纳德制药公司 治疗肺癌的吡铂和氨柔比星
US20120123121A1 (en) * 2009-06-12 2012-05-17 Poniard Pharmaceuticals, Inc. Synthesis of picoplatin
RU2451010C1 (ru) * 2011-01-11 2012-05-20 Закрытое Акционерное Общество "Ива Фарм" Палладиево-медные катализаторы гомогенного селективного окисления тиольных групп, комбинация и композиция на их основе и способ терапевтического воздействия
CN105254679B (zh) * 2013-11-19 2018-05-15 辽宁大学 单6-(氮杂环取代)蒽醌二氯化铂配合物及其制备方法和应用
CN103860539B (zh) * 2014-04-14 2016-02-10 于迎涛 一种具有混合轴向配体的Pt（IV）类抗癌药物及制备方法
CN104231000A (zh) * 2014-08-20 2014-12-24 山东铂源药业有限公司 一种抗肿瘤药物甲啶铂的合成方法
US10987353B2 (en) 2016-05-04 2021-04-27 The Wistar Institute Of Anatomy And Biology Methods of treating cancers overexpressing CARM1 with EZH2 inhibitors and platinum-based antineoplastic drugs
KR102137669B1 (ko) * 2019-08-05 2020-07-27 한국과학기술연구원 메탄올 또는 그 전구체 합성용 촉매, 이의 제조방법 및 이를 이용한 메탄올 또는 그 전구체의 제조방법
BR112023000125A2 (pt) 2020-07-08 2023-04-11 Dayton Therapeutics Ag Satraplatina para uso no tratamento de neoplasias linfoides
CN113402565B (zh) * 2021-06-16 2023-07-28 中国人民解放军空军军医大学 一类含有泊沙康唑的四价铂配合物、制备方法及其应用
WO2023131524A1 (en) 2022-01-07 2023-07-13 Dayton Therapeutics Ag Treating haematological malignancies by means of satraplatin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2060615B (en) * 1979-08-23 1983-06-22 Johnson Matthey Co Ltd Platinum-amine complexes
US4533502A (en) 1983-02-22 1985-08-06 Rochon Fernande D Platinum (II) compounds and their preparation
ATE63919T1 (de) * 1984-06-27 1991-06-15 Johnson Matthey Plc Platinkoordinationsverbindungen.
US5244919A (en) 1988-02-02 1993-09-14 Johnson Matthey, Inc. Pt(IV) complexes as anti-tumor agents
GB9105037D0 (en) 1991-03-09 1991-04-24 Johnson Matthey Plc Improvements in chemical compounds
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
US5547982A (en) * 1995-02-27 1996-08-20 Johnson Matthey, Inc. Anti-tumor platinum complexes
BR0011678A (pt) 1999-03-19 2002-02-26 Anormed Inc Composições farmacêuticas compreendendo complexos de metal
WO2000061590A1 (en) 1999-04-13 2000-10-19 Anormed, Inc. Process for preparing amine platinum complexes

Also Published As

Publication number Publication date
HK1039336B (zh) 2006-01-27
CZ303156B6 (cs) 2012-05-09
JP2002541263A (ja) 2002-12-03
NZ514736A (en) 2004-01-30
TWI289565B (en) 2007-11-11
HK1100562A1 (en) 2007-09-21
CN100460412C (zh) 2009-02-11
NO20014957D0 (no) 2001-10-12
CN1350540A (zh) 2002-05-22
CN1916009B (zh) 2010-12-15
KR100711955B1 (ko) 2007-05-02
CA2368849C (en) 2011-01-25
BR0009780A (pt) 2002-01-02
DE60023859T2 (de) 2006-08-03
KR20020018189A (ko) 2002-03-07
HK1039336A1 (en) 2002-04-19
CY1104965T1 (el) 2010-03-03
CN1916009A (zh) 2007-02-21
CN1250559C (zh) 2006-04-12
BR0009780B1 (pt) 2013-09-24
ATE309257T1 (de) 2005-11-15
EP1165576B1 (en) 2005-11-09
HUP0200748A2 (hu) 2002-07-29
RU2245340C2 (ru) 2005-01-27
SK286374B6 (sk) 2008-08-05
MY122706A (en) 2006-04-29
ZA200107965B (en) 2003-01-02
HUP0200748A3 (en) 2010-01-28
NO20014957L (no) 2001-12-03
IS2711B3 (is) 2011-01-15
PL351612A1 (en) 2003-05-05
MXPA01010430A (es) 2002-03-27
AR043084A1 (es) 2005-07-20
PL202731B1 (pl) 2009-07-31
BG106090A (en) 2002-06-28
UA71614C2 (en) 2004-12-15
AU770006B2 (en) 2004-02-12
EE04747B1 (et) 2006-12-15
ES2253214T3 (es) 2006-06-01
IL145671A0 (en) 2002-06-30
SK14682001A3 (sk) 2002-01-07
CA2368849A1 (en) 2000-10-19
EP1165576A1 (en) 2002-01-02
CN1847253A (zh) 2006-10-18
EE200100536A (et) 2003-02-17
CZ20013648A3 (cs) 2002-02-13
DK1165576T3 (da) 2006-03-27
US6518428B1 (en) 2003-02-11
WO2000061590A1 (en) 2000-10-19
NO330429B1 (no) 2011-04-11
AU3951000A (en) 2000-11-14
JP4756669B2 (ja) 2011-08-24
DE60023859D1 (de) 2005-12-15
IS6092A (is) 2001-09-28
BG65429B1 (bg) 2008-07-31

Similar Documents

Publication Publication Date Title
IS2709B (is) Aðferð til framleiðslu á amín platínu komplexum
IS2223B (is) Aðferð til framleiðslu á 5-sýanóþalíði
IS2261B (is) Aðferð til framleiðslu á 5-sýanóþalíði
IS6286A (is) Efnasambönd til meðhöndlunar á blóðþurrð
FI20010154A (fi) Menetelmä citalopramin valmistamiseksi
IS5715A (is) Aðferð til smíði á 4-karboxýamínó-2-setnu-1,2,3,4-tetrahýdrókínólíni
IS5600A (is) Aðferð til framleiðslu á vernduðu 4-amínómetýl-pýrrólidín-3-óni.
IS7153A (is) Aðferð til framleiðslu á 14-hýdroxýnormorfínon afleiðu
NO20002319D0 (no) FremgangsmÕte for fremstilling av fulven-metallkomplekser
NO20030515D0 (no) Fremgangsmåte for fremstilling av dinapsolin
NO20005148L (no) FremgangsmÕte for Õ fremstille 4-substituerte-1H-indol-3- glyoksamider
DK1005476T3 (da) Fremgangsmåde til fremstilling af rutheniumkomplekser
NO20022956L (no) Fremgangsmate for fremstilling av nitroguanidin
NO20011652D0 (no) Fremgangsmåte for fremstilling av 1,5-diaryl-3-substituerte pyrazoler
HK1040248A1 (en) Process for the preparation of isoindoline.
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
IS5020A (is) Aðferð til framleiðslu á fenoxýfenýlsúlfónýl halíðum
IS5212A (is) Bætt aðferð til framleiðslu á pýrazólópýrimidínónafleiðu
DK1226125T3 (da) Fremgangsmåde til fremstilling af mavesårsmidler
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
NO20023702D0 (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20002558D0 (no) FremgangsmÕte for fremstilling av findisperse eksplosivstoffer
FI991618A (fi) Menetelmä massan valmistamiseksi
TH34294B (th) กระบวนการสำหรับการเตรียมคลอโรเบบโซซาโซล
SE9901903D0 (sv) Novel process